Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)

NCT03520127 is registered in ClinicalTrials.gov with Medtronic Surgical Technologies as lead sponsor.

NCT NCT03520127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03520127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Registry Study Evaluating Outcomes in Breast Biopsy With the Intact™ Breast Lesion Excision System (BLES)
Lead sponsor
Medtronic Surgical Technologies
Phase
Observational
Overall status
Terminated
Start date
September 27, 2017
Completion date
February 28, 2019
Enrollment
176 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

breast lesions